AI assistant
Shattuck Labs, Inc. — Director's Dealing 2020
Oct 9, 2020
34607_dirs_2020-10-08_1adf45d6-3fff-41bc-8d37-a146208ef879.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Shattuck Labs, Inc. (STTK)
CIK: 0001680367
Period of Report: 2020-10-08
Reporting Person: Pandite Arundathy N. (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100303 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.01 | 2027-12-21 | Common Stock (5863) | Direct | |
| Stock Option (Right to Buy) | $2.95 | 2028-09-18 | Common Stock (63705) | Direct | |
| Stock Option (Right to Buy) | $4.67 | 2030-08-05 | Common Stock (82200) | Direct |
Footnotes
F1: Includes 16,789 restricted stock units, which will vest in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer.
F2: This option represents a right to purchase a total of 5,863 shares of the Issuer's common stock, 527 of which have vested, with the remaining shares vesting in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer.
F3: This option represents a right to purchase a total of 63,705 shares of the Issuer's common stock, 37,161 of which have vested, with the remaining shares vesting in equal monthly installments through May 15, 2022, subject to the Reporting Person's continued service to the Issuer.
F4: This option represents a right to purchase a total of 82,200 shares of the Issuer's common stock, one quarter of which will vest on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer.